abagovomab 21
abciximab 20
abituzumab 18
abrilumab 11
actoxumab 11
adalimumab 13
aducanumab 8
afasevikumab 12
alacizumab_pegol 10
alemtuzumab 21
alirocumab 15
amatuximab 28
andecaliximab 18
anifrolumab 17
anrukinzumab 15
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 16
ascrinvacumab 4
atezolizumab 13
atinumab 12
avelumab 9
basiliximab 17
bavituximab 27
begelomab 20
benralizumab 19
bevacizumab_beta 12
bezlotoxumab 11
bimagrumab 8
bleselumab 9
blinatumomab 25
blosozumab 23
bococizumab 13
brazikumab 10
brentuximab_vedotin 17
briakinumab 14
brodalumab 5
brolucizumab 18
brontictuzumab 16
burosumab 13
cabiralizumab 15
camrelizumab 10
canakinumab 20
cantuzumab_ravtansin 33
carlumab 11
carotuximab 17
cergutuzumab_amunaleukin2 20
cergutuzumab_amunaleukin 20
certolizumab_pegol 18
cetiximab 31
citatuzumab_bogatox 23
cixutumumab 18
clivatuzumab_tetraxetan 9
codrituzumab 19
conatumumab 5
concizumab 22
crenezumab 9
crizanlizumab 18
crotedumab 13
dacetuzumab 17
daclizumab 10
dalotuzumab 21
dapirolizumab_pegol 19
daratumumab 13
dectrekumab 8
demcizumab 14
denosumab 10
depatuxizumab 16
depatuxizumab_mafodotin 16
dezamizumab 13
dinutuximab 30
diridavumab 13
domagrozumab 13
drozitumab 11
duligotuzumab 18
durvalumab 4
dusigitumab 3
efalizumab 26
efungumab 23
eldelumab 10
elezanumab 7
elgemtumab 8
elotuzumab 10
emactuzumab 15
emapalumab 18
emibetuzumab 10
enavatuzumab 22
enfortumab_vedotin 8
enoblituzumab 15
enokizumab 18
enoticumab 14
ensituximab 25
eptinezumab 17
erenumab 9
etaracizumab 14
etrolizumab 15
evinacumab 15
evolocumab 3
farletuzumab 4
fasinumab 18
fezakinumab 11
fibatuzumab 5
ficlatuzumab 13
firivumab 27
flanvotumab 12
fletikumab 12
foralumab 8
foravirumab 9
fremanezumab 22
fresolimumab 16
fulranumab 14
futuximab 11
galcanezumab 13
ganitumab 16
gantenerumab 10
gemetuzumab 18
gemtuzumab2 18
gemtuzumab 17
gevokizumab 18
girentuximab 14
glembatumumab 9
glembatumumab_vedotin 9
guselkumab 19
ibalizumab 18
ibritumomab 18
icrucumab 6
idarucizumab 18
ifabotuzumab 5
imalumab 14
imgatuzumab 12
inclacumab 8
indatuximab_ravtansin 23
indusatumab 7
inebilizumab 20
intetumumab 7
iodine_girentuximab 24
ipilimumab 3
iratumumab 6
isatuximab 25
itolizumab 22
ixekizumab 22
labetuzumab_govitecan 15
lambrolizumab 17
lampalizumab 19
lanadelumab 15
landogrozumab 16
laprituximab 19
lebrikizumab 29
lendalizumab 17
lenzilumab 8
lifastuzumab_vedotin 20
ligelizumab 19
lilotomab 27
lirilumab 10
lodelcizumab 10
lokivetmab 20
lorvotuzumab_mertansin 13
lucatumumab 20
lumretuzumab 10
lupartumab 7
lutikizumab 16
margetuximab 25
milatuzumab 25
mirvetuximab 21
mirvetuximab_soravtansin 21
modotuximab 24
mogamulizumab 20
monalizumab 15
motavizumab 23
moxetumomab_pasudotox 23
namilumab 8
naratuximab 20
naratuximab_emtansin 20
narnatumab 11
navicixizumab2 22
navicixizumab 18
navivumab 28
necitumumab 6
nemolizumab 19
nesvacumab 12
nivolumab 10
obiltoxaximab 14
obinutuzumab 23
ocaratuzumab 24
ofatumumab 11
olaratumab 9
olokizumab 20
omalizumab 16
onartuzumab 15
ontuxizumab 14
opicinumab 13
orticumab 9
otelixizumab 29
oxelumab 9
ozanezumab 18
pamrevlumab 6
panobacumab 10
parsatuzumab 15
pasotuxizumab 19
pateclizumab 12
patritumab 13
pembrolizumab 17
perakizumab 13
pidilizumab 16
pinatuzumab_vedotin 10
plozalizumab 20
pogalizumab 19
polatuzumab_vedotin 16
ponezumab 27
prezalumab 12
pritoxaximab 18
quilizumab 15
racotumomab 17
radretumab 13
ralpancizumab 18
ramucirumab 13
ranevetmab 17
ranibizumab 16
refanezumab 16
remtolumab 12
rilotumumab 8
rinucumab 14
risankizumab 27
rituximab 12
rivabazumab 12
robatumumab 18
roledumab 21
romosozumab 16
rontalizumab 17
rosmantuzumab 12
rozanolixizumab 13
sacituzumab 15
sacituzumab_govitecan 15
samalizumab 16
sapelizumab 20
sarilumab 9
secukinumab 8
seribantumab 12
setoxaximab 33
sifalimumab 5
siltuximab 19
simtuzumab 18
sirukumab 6
solanezumab 18
solitomab 15
stamulumab 13
suptavumab 13
suvizumab 10
tabalumab 8
tadocizumab 11
tamtuvetmab 25
tanezumab 20
tarextumab 7
tavolixizumab 11
telisotuzumab 24
teplizumab 13
tesidolumab 14
tezepelumab 18
tigatuzumab 15
tildrakizumab 18
timolumab 7
tisotumab 3
tosatoxumab 28
tositumomab 18
tralokinumab 12
trastuzumab 19
tregalizumab 20
trevogrumab 11
ublituximab 23
urelumab 13
ustekinumab 21
utomilumab 21
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 4
vantictumab 13
vanucizumab2 12
vanucizumab 18
varlilumab 10
vatelizumab 16
vedolizumab 14
veltuzumab 8
vesencumab 10
vorsetuzumab 14
vorsetuzumab_mafodotin 14
vunakizumab 21
xentuzumab 15
zatuximab 24
